Vaccine News and Research

Latest Vaccine News and Research

Positive preliminary results from Soligenix's SGX202 in GARS model

Soligenix, Inc., a late-stage biopharmaceutical company, announced today promising preliminary results from a preclinical study of SGX202 in a canine gastrointestinal acute radiation syndrome model.

19 Jan 2011

Scripps Research receives NIH grant to develop therapies for circadian rhythm disorders

The Scripps Research Institute has been awarded $3.17 million over four years to develop compounds that will counteract disruptions of the human biological clock - the circadian rhythm that regulates our patterns of activity and rest over a 24-hour daily cycle.

19 Jan 2011

WHO Director-General opens executive board session with calls for reform

Kicking off a nine-day annual WHO executive board meeting Monday, WHO Director-General Margaret Chan called for the board to consider areas where the agency can redirect resources in a more targeted manner so as to achieve greater outcomes, Reuters reports.

19 Jan 2011

UMMS begins MBL-HCV1 Phase 2 trial to prevent hepatitis C virus infection in liver transplant patients

Following a successful Phase 1 study for safety, researchers at MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 2 clinical trial testing the ability of a human monoclonal antibody they developed to prevent hepatitis C virus infection of a donor liver in transplant patients.

19 Jan 2011

Australians urged to vaccinate babies and care givers against whooping cough

The number of cases of the deadly whooping cough in the Hume region in Victoria, including Wodonga, last year increased fivefold from those diagnosed in 2008. A total 67 cases were reported in Albury last year but across the Greater Southern region there were more than 1,000 cases. The outbreak reached its peak in September. In the last three years 1,416 West Australians contracted the disease, three of whom died.

18 Jan 2011

iBio grants commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos for new yellow fever vaccine

iBio, Inc. today announced the grant of a commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos of Brazil to develop, manufacture and sell certain vaccines based upon iBio's proprietary technology. Fiocruz/Bio-Manguinhos will invest more than $6 million to bring the first product - a new yellow fever vaccine - through Phase I clinical trials.

18 Jan 2011

Few opt for vaccine to prevent painful shingles, NPR reports

[T]he fact is only about 10% of the 50 million people who should get the vaccine actually have. … The vaccine is expensive — $160 a shot, plus an administration fee.

18 Jan 2011

Viewpoints: Next step after health law repeal effort; Refuting 'job-killing' claims; Mental health care

The continuing resolution that extended funding for the federal government until Mar. 4 gives us an opportunity to include language in the appropriations that fund the rest of this fiscal year — and must be passed to avoid a government shutdown. The language would prohibit any funds from being used to implement or enforce Obamacare (Rep. Steve King, 1/18).

18 Jan 2011

Vaccine to prevent MRSA infections after bone and joint surgery

University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.

18 Jan 2011

Scientists create GM chicken that does not spread bird flu to other chickens

"Scientists have developed genetically modified [GM] chickens that don't transmit bird flu [H5N1] to other chickens," HealthDay News/Bloomberg Businessweek reports.

18 Jan 2011

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the "experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection" against malaria, Reuters reports.

18 Jan 2011

New evidence about broadly-reactive neutralizing antibodies that block HIV infection

New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.

14 Jan 2011

Vanderbilt, Scripps Research form partnership to open new institute

The Scripps Research Institute and Vanderbilt University have formed a partnership to advance science at the interface of chemistry and medicine, the institutions announced today.

14 Jan 2011

Viewpoints: Health law repeal; Individual mandate; Essential benefits package; Arizona transplant program

If the government fails, then costs will rise inexorably. Nothing in the law guarantees success: The law embodies almost every idea anyone has offered and hopes a couple of them will work.

14 Jan 2011

Study reports long-term complications in childhood survivors of bacterial meningitis

Nearly half of children who survive an episode of bacterial meningitis experience persistent behavioral, intellectual, or other complications, reports a study in the January issue of The Pediatric Infectious Disease Journal.

14 Jan 2011

ITM scientists to combat tapeworm infection using drugs

The Institute of Tropical Medicine Antwerp increases its fight in Congo against the pork tapeworm, in spite of its name also a human parasite, causing epilepsy.

14 Jan 2011

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.

14 Jan 2011

Personal genetic tests have promising effects on consumers

New findings from a landmark research study led by Scripps Health and the Scripps Translational Science Institute (STSI) reveal that personal genetic tests have some promising effects on consumers who choose to undergo the screenings. STSI is an initiative of Scripps Health in collaboration with The Scripps Research Institute.

13 Jan 2011

Antibiotic treatment may be sufficient to overcome River Blindness

The team found that a bacterium inside the worm acts as a 'disguise' for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body's natural defences, but once the bacteria are removed with antibiotics, the immune system responds appropriately, releasing cells, called eosinophils, that kill the worm.

13 Jan 2011

New discovery has brought dream of transforming measles virus against cancer

When most people in the developed world think of measles, what comes to mind is only a dim memory of a vaccination at a pediatrician's office. But while childhood vaccination has virtually eliminated measles from North America and much of Europe, researchers remain interested in the virus.

13 Jan 2011

Vaccine News and Research

Latest Vaccine News and Research

Positive preliminary results from Soligenix's SGX202 in GARS model

Scripps Research receives NIH grant to develop therapies for circadian rhythm disorders

WHO Director-General opens executive board session with calls for reform

UMMS begins MBL-HCV1 Phase 2 trial to prevent hepatitis C virus infection in liver transplant patients

Australians urged to vaccinate babies and care givers against whooping cough

iBio grants commercial, royalty-bearing license to Fiocruz/Bio-Manguinhos for new yellow fever vaccine

Few opt for vaccine to prevent painful shingles, NPR reports

Viewpoints: Next step after health law repeal effort; Refuting 'job-killing' claims; Mental health care

Vaccine to prevent MRSA infections after bone and joint surgery

Scientists create GM chicken that does not spread bird flu to other chickens

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

New evidence about broadly-reactive neutralizing antibodies that block HIV infection

Vanderbilt, Scripps Research form partnership to open new institute

Viewpoints: Health law repeal; Individual mandate; Essential benefits package; Arizona transplant program

Study reports long-term complications in childhood survivors of bacterial meningitis

ITM scientists to combat tapeworm infection using drugs

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

Personal genetic tests have promising effects on consumers

Antibiotic treatment may be sufficient to overcome River Blindness

New discovery has brought dream of transforming measles virus against cancer

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in